loteprednol etabonate
- Product NDC
- 82260-361
- 11-digit product format
- 822600361
- Labeler code
- 82260
- Product ID
- 82260-361_4a467df9-02df-061f-e063-6294a90a3beb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- loteprednol etabonate
- Dosage form
- SUSPENSION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Bausch & Lomb Americas Inc.
- Application
- NDA020803
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-02-09
- Substance
- LOTEPREDNOL ETABONATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- loteprednol etabonate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LOTEPREDNOL ETABONATE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YEH1EZ96K6 |
| Rxcui | 311381 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82260-361-05 | loteprednol etabonate | 5 mL in 1 BOTTLE, DROPPER | SUSPENSION/ DROPS | 5 | | 4 |
| 82260-361-05 | loteprednol etabonate | 1 in 1 CARTON | SUSPENSION/ DROPS | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 82260-361 | LOTEPREDNOL ETABONATE SUSPENSION/ DROPS [BAUSCH & LOMB AMERICAS INC.] | 3 | Current NDC, 2 package rows | 20250206_7714824b-29ed-442a-ad2d-13ee2fc6bc42.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 82260-361-05 | 82260036105 | 1 BOTTLE, DROPPER in 1 CARTON (82260-361-05) / 5 mL in 1 BOTTLE, DROPPER | 2024-02-09 | No | No | Current |